Difficulties in recognition of pyruvate dehydrogenase complex deficiency on the basis of clinical and biochemical features. The role of next-generation sequencing
Pyruvate dehydrogenase complex (PDHc) defect is a well-known cause of mitochondrial disorders (MD) with at least six responsible genes (PDHA1, PDHB, DLAT, DLD, PDHX, PDP1). The aim of this work was to assess the diagnostic value of biochemical methods in recognition of PDHc defect in Polish patients...
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-06-01
|
Series: | Molecular Genetics and Metabolism Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214426916300167 |
id |
doaj-1d7800cfa3654508be355f228f9e59ce |
---|---|
record_format |
Article |
spelling |
doaj-1d7800cfa3654508be355f228f9e59ce2020-11-24T21:09:33ZengElsevierMolecular Genetics and Metabolism Reports2214-42692016-06-017C707610.1016/j.ymgmr.2016.03.004Difficulties in recognition of pyruvate dehydrogenase complex deficiency on the basis of clinical and biochemical features. The role of next-generation sequencingE. Ciara0D. Rokicki1P. Halat2A. Karkucińska-Więckowska3D. Piekutowska-Abramczuk4J. Mayr5J. Trubicka6T. Szymańska-Dębińska7M. Pronicki8M. Pajdowska9M. Dudzińska10M. Giżewska11M. Krajewska-Walasek12J. Książyk13W. Sperl14R. Płoski15E. Pronicka16Department of Medical Genetics, The Children's Memorial Health Institute, Warsaw, PolandDepartment of Pediatrics, Nutrition and Metabolic Diseases, The Children's Memorial Health Institute, Warsaw, PolandDepartment of Medical Genetics, The Children's Memorial Health Institute, Warsaw, PolandDepartment of Pathology, The Children's Memorial Health Institute, Warsaw, PolandDepartment of Medical Genetics, The Children's Memorial Health Institute, Warsaw, PolandDepartment of Pediatrics, Paracelsus Medical University, Salzburg, AustriaDepartment of Medical Genetics, The Children's Memorial Health Institute, Warsaw, PolandDepartment of Pathology, The Children's Memorial Health Institute, Warsaw, PolandDepartment of Pathology, The Children's Memorial Health Institute, Warsaw, PolandDepartment of Biochemistry and Experimental Medicine, The Children's Memorial Health Institute, Warsaw, PolandDepartment of Child Neurology, Chorzowskie Centrum Pediatrii i Onkologii, Chorzów, PolandDepartment of Pediatrics, Endocrinology, Diabetology, Metabolic Diseases and Cardiology, Pomeranian Medical University, Szczecin, PolandDepartment of Medical Genetics, The Children's Memorial Health Institute, Warsaw, PolandDepartment of Pediatrics, Nutrition and Metabolic Diseases, The Children's Memorial Health Institute, Warsaw, PolandDepartment of Pediatrics, Paracelsus Medical University, Salzburg, AustriaDepartment of Medical Genetics, Warsaw Medical University, Warsaw, PolandDepartment of Medical Genetics, The Children's Memorial Health Institute, Warsaw, PolandPyruvate dehydrogenase complex (PDHc) defect is a well-known cause of mitochondrial disorders (MD) with at least six responsible genes (PDHA1, PDHB, DLAT, DLD, PDHX, PDP1). The aim of this work was to assess the diagnostic value of biochemical methods in recognition of PDHc defect in Polish patients with suspicion of MD. In the first step, Western blot of the E1α subunit was performed on 86 archive muscle bioptates with suspicion of MD. In the second step, Sanger PDHA1 sequencing was performed in 21 cases with low E1α expression. In the third step, 7 patients with negative results of PDHA1 sequencing were subjected to whole-exome sequencing (WES). This protocol revealed 4 patients with PDHA1 and one with DLD mutations. Four additional probands were diagnosed outside the protocol (WES or Sanger sequencing). The molecular characterization of PDHc defect was conducted in a total of 9 probands: 5 according to and 4 off the protocol. Additionally, two affected relatives were recognized by a family study. Altogether we identified seven different PDHA1 changes, including two novel variants [c.464T > C (p.Met155Thr) and c.856_859dupACTT (p.Arg288Leufs*10)] and one DLD variant. The lactate response to glucose load in the PDHA1 subset was compared to a subset of non PDHc-related MD. Opposite responses were observed, with an increase of 23% and decrease of 27%, respectively. The results show that determining lactate response to glucose load and muscle E1α expression may contribute to distinguishing PDHc-related and other MD, however, WES is becoming the method of choice for MD diagnostics.http://www.sciencedirect.com/science/article/pii/S2214426916300167Pyruvate dehydrogenase complex deficiencyPDHcPDHA1DLDNovel pathogenic variantsWhole-exome sequencing |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
E. Ciara D. Rokicki P. Halat A. Karkucińska-Więckowska D. Piekutowska-Abramczuk J. Mayr J. Trubicka T. Szymańska-Dębińska M. Pronicki M. Pajdowska M. Dudzińska M. Giżewska M. Krajewska-Walasek J. Książyk W. Sperl R. Płoski E. Pronicka |
spellingShingle |
E. Ciara D. Rokicki P. Halat A. Karkucińska-Więckowska D. Piekutowska-Abramczuk J. Mayr J. Trubicka T. Szymańska-Dębińska M. Pronicki M. Pajdowska M. Dudzińska M. Giżewska M. Krajewska-Walasek J. Książyk W. Sperl R. Płoski E. Pronicka Difficulties in recognition of pyruvate dehydrogenase complex deficiency on the basis of clinical and biochemical features. The role of next-generation sequencing Molecular Genetics and Metabolism Reports Pyruvate dehydrogenase complex deficiency PDHc PDHA1 DLD Novel pathogenic variants Whole-exome sequencing |
author_facet |
E. Ciara D. Rokicki P. Halat A. Karkucińska-Więckowska D. Piekutowska-Abramczuk J. Mayr J. Trubicka T. Szymańska-Dębińska M. Pronicki M. Pajdowska M. Dudzińska M. Giżewska M. Krajewska-Walasek J. Książyk W. Sperl R. Płoski E. Pronicka |
author_sort |
E. Ciara |
title |
Difficulties in recognition of pyruvate dehydrogenase complex deficiency on the basis of clinical and biochemical features. The role of next-generation sequencing |
title_short |
Difficulties in recognition of pyruvate dehydrogenase complex deficiency on the basis of clinical and biochemical features. The role of next-generation sequencing |
title_full |
Difficulties in recognition of pyruvate dehydrogenase complex deficiency on the basis of clinical and biochemical features. The role of next-generation sequencing |
title_fullStr |
Difficulties in recognition of pyruvate dehydrogenase complex deficiency on the basis of clinical and biochemical features. The role of next-generation sequencing |
title_full_unstemmed |
Difficulties in recognition of pyruvate dehydrogenase complex deficiency on the basis of clinical and biochemical features. The role of next-generation sequencing |
title_sort |
difficulties in recognition of pyruvate dehydrogenase complex deficiency on the basis of clinical and biochemical features. the role of next-generation sequencing |
publisher |
Elsevier |
series |
Molecular Genetics and Metabolism Reports |
issn |
2214-4269 |
publishDate |
2016-06-01 |
description |
Pyruvate dehydrogenase complex (PDHc) defect is a well-known cause of mitochondrial disorders (MD) with at least six responsible genes (PDHA1, PDHB, DLAT, DLD, PDHX, PDP1). The aim of this work was to assess the diagnostic value of biochemical methods in recognition of PDHc defect in Polish patients with suspicion of MD.
In the first step, Western blot of the E1α subunit was performed on 86 archive muscle bioptates with suspicion of MD. In the second step, Sanger PDHA1 sequencing was performed in 21 cases with low E1α expression. In the third step, 7 patients with negative results of PDHA1 sequencing were subjected to whole-exome sequencing (WES). This protocol revealed 4 patients with PDHA1 and one with DLD mutations. Four additional probands were diagnosed outside the protocol (WES or Sanger sequencing).
The molecular characterization of PDHc defect was conducted in a total of 9 probands: 5 according to and 4 off the protocol. Additionally, two affected relatives were recognized by a family study. Altogether we identified seven different PDHA1 changes, including two novel variants [c.464T > C (p.Met155Thr) and c.856_859dupACTT (p.Arg288Leufs*10)] and one DLD variant.
The lactate response to glucose load in the PDHA1 subset was compared to a subset of non PDHc-related MD. Opposite responses were observed, with an increase of 23% and decrease of 27%, respectively.
The results show that determining lactate response to glucose load and muscle E1α expression may contribute to distinguishing PDHc-related and other MD, however, WES is becoming the method of choice for MD diagnostics. |
topic |
Pyruvate dehydrogenase complex deficiency PDHc PDHA1 DLD Novel pathogenic variants Whole-exome sequencing |
url |
http://www.sciencedirect.com/science/article/pii/S2214426916300167 |
work_keys_str_mv |
AT eciara difficultiesinrecognitionofpyruvatedehydrogenasecomplexdeficiencyonthebasisofclinicalandbiochemicalfeaturestheroleofnextgenerationsequencing AT drokicki difficultiesinrecognitionofpyruvatedehydrogenasecomplexdeficiencyonthebasisofclinicalandbiochemicalfeaturestheroleofnextgenerationsequencing AT phalat difficultiesinrecognitionofpyruvatedehydrogenasecomplexdeficiencyonthebasisofclinicalandbiochemicalfeaturestheroleofnextgenerationsequencing AT akarkucinskawieckowska difficultiesinrecognitionofpyruvatedehydrogenasecomplexdeficiencyonthebasisofclinicalandbiochemicalfeaturestheroleofnextgenerationsequencing AT dpiekutowskaabramczuk difficultiesinrecognitionofpyruvatedehydrogenasecomplexdeficiencyonthebasisofclinicalandbiochemicalfeaturestheroleofnextgenerationsequencing AT jmayr difficultiesinrecognitionofpyruvatedehydrogenasecomplexdeficiencyonthebasisofclinicalandbiochemicalfeaturestheroleofnextgenerationsequencing AT jtrubicka difficultiesinrecognitionofpyruvatedehydrogenasecomplexdeficiencyonthebasisofclinicalandbiochemicalfeaturestheroleofnextgenerationsequencing AT tszymanskadebinska difficultiesinrecognitionofpyruvatedehydrogenasecomplexdeficiencyonthebasisofclinicalandbiochemicalfeaturestheroleofnextgenerationsequencing AT mpronicki difficultiesinrecognitionofpyruvatedehydrogenasecomplexdeficiencyonthebasisofclinicalandbiochemicalfeaturestheroleofnextgenerationsequencing AT mpajdowska difficultiesinrecognitionofpyruvatedehydrogenasecomplexdeficiencyonthebasisofclinicalandbiochemicalfeaturestheroleofnextgenerationsequencing AT mdudzinska difficultiesinrecognitionofpyruvatedehydrogenasecomplexdeficiencyonthebasisofclinicalandbiochemicalfeaturestheroleofnextgenerationsequencing AT mgizewska difficultiesinrecognitionofpyruvatedehydrogenasecomplexdeficiencyonthebasisofclinicalandbiochemicalfeaturestheroleofnextgenerationsequencing AT mkrajewskawalasek difficultiesinrecognitionofpyruvatedehydrogenasecomplexdeficiencyonthebasisofclinicalandbiochemicalfeaturestheroleofnextgenerationsequencing AT jksiazyk difficultiesinrecognitionofpyruvatedehydrogenasecomplexdeficiencyonthebasisofclinicalandbiochemicalfeaturestheroleofnextgenerationsequencing AT wsperl difficultiesinrecognitionofpyruvatedehydrogenasecomplexdeficiencyonthebasisofclinicalandbiochemicalfeaturestheroleofnextgenerationsequencing AT rpłoski difficultiesinrecognitionofpyruvatedehydrogenasecomplexdeficiencyonthebasisofclinicalandbiochemicalfeaturestheroleofnextgenerationsequencing AT epronicka difficultiesinrecognitionofpyruvatedehydrogenasecomplexdeficiencyonthebasisofclinicalandbiochemicalfeaturestheroleofnextgenerationsequencing |
_version_ |
1716758036023869440 |